主要研究成果
近几年发表的国际会议报告：
1. 第16届世界精神病学大会：Predictors of readmission in a large psychiatric hospital in Guangzhou China. （2014年9月，西班牙马德里）
2. 第16届世界精神病学大会：Developing health service research for quality improvement in Guangzhou China.（2014年9月，西班牙马德里）
3. 世界精神病学会地区会议--亚洲精神卫生阴阳两级平衡：Risk factors associated with 1-year readmission in patients with schizophrenia. （2014年12月，香港）
4. 中加生物精神医学论坛：Mental health service research in a large psychiatric hospital in Guangzhou China. （2015年9月，加拿大埃德蒙顿）
5. 第二届多伦多大学-广州医科大学附属脑科医院生物精神医学论坛：Clinical trial of ketamine ECT in treatment resistant Depression. （2019年5月，加拿大多伦多）
6. 香港第12届生物精神科科学会年会--神经环路：从神经发育到干预：“Ketamine plus ECT” for depression: An Added Benefits?. （2019年5月，香港）
近几年发表论文：(*Corresponding author)
1. Ma Y, Rosenheck R, Ye B, Fan N, He H*. Effectiveness of electroconvulsive therapy in patients with "less treatment-resistant" depression by the Maudsley Staging Model. Brain Behav.（IF=2.072）2020;e01654. doi:10.1002/brb3.1654.
2. Ma Y, Rosenheck R, He H*. Psychological Stress among Health Care Professionals during the 2019 Novel Coronavirus Disease Outbreak: Cases from Online Consulting Customers. Intensive Crit Care Nurs. 2020 Jun 28:102905.
3. Luo Y, Yu Y, Zhang ML, He H, Fan N*. Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling， Molecular Psychiatry，2020，IF=11.97
4. Ma Y, Rosenheck R，Fan N，He H*. Rates and Patient Characteristics of Electro convulsive Therapy in China and Comparisons With the United States. J ECT. 2019 Dec;35(4):251-257.
5. Luo Y, He H, Zhang J, Ou Y, Fan N*. Changes in serum TNF-α, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge.Compr Psychiatry. 2019 Feb 8;90:82-87. （并列第一）
6. Lin X, Rosenheck R, Sun B, Xie G, Zhong G, Tan C, Li Z, Yu M, He H*. Associative stigma experienced by mental health professionals in China and the United States. Soc Psychiatry Psychiatr Epidemiol. 2019 Jun;54(6):745-753
7. Ke X, Ding Y, Xu K, He H, Wang D, Deng X, Zhang X, Zhou Y, Zhou C, Liu Y, Ning Y, Fan N*. The profile of cognitive impairments in chronic ketamine users. Psychiatry Res. 2018 Aug;266:124-131.
8. He H*, Chang Q, Ma Y. The Association of Insight and Change in Insight with Clinical Symptoms in Depressed Inpatients. Shanghai Arch Psychiatry. 2018 Apr 25;30(2): 110- 118.
9. Zhang M, He H, Ning Y, Ding Y, Ke X, Wang D, Deng X, Fan N. Low serum level of epidermal growth factor in chronic ketamine users. Hum Psychopharmacol. 2018 May;33(3):e2656.
10. Zhang M, Rosenheck R, Lin X, Li Q, Zhou Y, Xiao Y, Huang X, Fan N, He H*. A randomized clinical trial of adjunctive ketamine anesthesia in electro-convulsive therapy for depression. J Affect Disord. 2018 Feb;227:372-378.
11. Huang X, Zhou Y, He H, Mei F, Sun B, Soares JC, Yang Zhang X. Association of serum BDNF levels with psychotic symptom in chronic patients with treatment-resistant depression in a Chinese Han population. Psychiatry Res. 2017 Nov;257:279-283.
12. Fan N, Luo Y, Ou Y, He H*. Altered serum levels of TNF-a, IL-6, and IL-18 in depressive disorder patients, Hum Psychopharmacol. 2017 Jun 5.
13. Zhou Y, Rosenheck R, Mohamed S, Ning Y, He H*. Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge.Psychiatry Res. 2017 Apr;250:129-135.
实验室预约